Related Experiment Video
Updated: Jul 7, 2026
07:20
Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis
Published on: October 18, 2024
Transforming pathways unleashed by a HDAC2 mutation in human cancer.
S Ropero1, E Ballestar, M Alaminos
1Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Oncogene
|February 12, 2008
Summary
Inactivating mutations in histone deacetylase-2 (HDAC2) promote cancer by upregulating tumor-promoting genes. Restoring wild-type HDAC2 represses these genes, suggesting HDAC2
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Histone modification patterns are disrupted in human cancers.
- The role of histone-modifying enzymes in cancer generation is poorly understood.
- Histone deacetylase-2 (HDAC2) is implicated in epigenetic gene repression.
Purpose of the Study:
- To investigate the expression signature associated with HDAC2-truncating mutations in cancer cells.
- To determine the mechanistic role of HDAC2 mutations in tumorigenesis.
- To explore the potential of HDAC2 as a therapeutic target.
Main Methods:
- Unsupervised clustering analysis of microsatellite-unstable colorectal cancer cell lines.
- Gene expression microarray analysis to compare HDAC2 mutant and wild-type cells.
- Chromatin immunoprecipitation (ChIP) to assess HDAC2 recruitment and histone acetylation.
- Transfection experiments to restore wild-type HDAC2 function.
Main Results:
- HDAC2 mutant cells exhibit a distinct expression signature compared to wild-type cells.
- Upregulation of tumor-promoting genes (tyrosine kinases, cell cycle mediators, angiogenic factors) in HDAC2 mutant cells.
- Loss of HDAC2 recruitment and increased histone H4 hyperacetylation at the promoters of these genes.
- Restoration of wild-type HDAC2 reversed the epigenetic pattern and repressed oncogenic genes.
Conclusions:
- HDAC2 mutations contribute to human tumorigenesis by derepressing key genes involved in cellular transformation.
- HDAC2 plays a critical role in maintaining epigenetic silencing of tumor-promoting genes.
- Targeting HDAC2 may offer a therapeutic strategy for cancers with HDAC2-inactivating mutations.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...